Rosenbaum & Rosenbaum, P.C. | July 25, 2012 | Defective Drugs
Harmful drugs are recalled every month – meaning the drugs were available for public consumption and widespread use prior to a recall being issued by the U.S. Food and Drug Administration. A study released on June 4, 2012, found that the FDA’s drug recall notification system is shockingly deficient in communicating the news of these recalls to doctors and patients, resulting in the continued use of dangerous products.
The FDA Recall Alert System was found to fail to report one fifth of Class I recalls over the past eight years. Class I recalls are the most important; issued for drugs that potentially cause serious adverse health consequences or death. Meanwhile, news of Class II and III recalls of products ranging from food to veterinary drugs is often more widely disseminated than that of a Class I deadly drug such as the contaminated blood thinner heparin, found to cause death to dialysis patients in 2008.
Health care providers being uninformed about clinically vital recalls is a serious threat to patient safety. One danger is doctors prescribing deadly medications. Improved tracking and notification systems are being suggested to the FDA for consideration, but until a system is put in place where 100% of the drug recalls are communicated to the public, patients should be aware that not all medications prescribed by medical professionals are safe products.
It is unknown how many patients have been harmed as a result of ingesting a drug that has been recalled. If you or a loved one has suffered serious injury from a defective drug product, you may have been prescribed one of the recalled drugs that were never reported by the FDA. If you have been injured because of a defective product, this new study will help an experienced attorney successfully compensate for your loss.